argenx SE
$160.129876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$160.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.07 (-0.04%) Today
$0.00 (0.00%) As of 4:55 AM EST after-hours
Why Robinhood?
You can buy or sell argenx SE and other stocks, options, ETFs, and crypto commission-free!
About ARGX
argenx SE American Depositary Shares, also called argenx SE, is a clinical-stage biotechnology company, which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include ARGX-113 for the treatment of autoimmune disease myasthenia gravis and ARGX-110 for the treatment of hematological cancer acute myeloid leukemia. Read More The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren on April 25, 2008 and is headquartered in Breda, the Netherlands.
Employees
105
Headquarters
Breda, Noord-Brabant
Founded
2008
Market Cap
6.92B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
98.52K
High Today
$160.44
Low Today
$158.58
Open Price
$159.26
Volume
73.50K
52 Week High
$169.50
52 Week Low
$106.49
Collections
Analyst Ratings
83%
of 18 ratings
Buy
83%
Hold
17%
Sell
0%
ARGX Earnings
-$1.34
-$0.83
-$0.32
$0.19
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Available Feb 27, Pre-Market
People Also Bought
Canopy Growth
179,101
$22.01
-0.54%GE
328,719
$12.66
-1.33%NVIDIA
92,238
$301.50
+4.04%Twilio
27,936
$128.14
+0.31%Lyft
56,392
$45.25
+1.25%Alibaba
140,333
$221.00
+0.62%Zoom
20,032
$99.74
+9.66%Cronos Group
191,872
$7.19
-2.04%Okta
16,207
$137.90
+0.63%BioTelemetry
1,256
$53.22
-0.56%Tilray
43,690
$17.11
-1.61%New Age Beverages
55,351